Article Abstract:
US biotech companies are raising money through IPOs on London's Alternative Investment Market, (AIM) which was set up to create a financial marketplace where small and speculative companies could find backing since they find it difficult to find finance despite having very good technology. While AIM offers biotechs the potential of cash and few regulatory strings, it still has its risks since analyst coverage of AIM stocks is light and past bad experiences.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
The measures that are being taken to use the inventions of the universities and research centers of the Greater Philadelphia region in developing its biotech and pharmaceutical businesses are discussed.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
The Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) is a regional nonprofit organization, which provides expertise and capital to other companies for their growth.
User Contributions:
Comment about this article or add new information about this topic: